Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Protocol for the development of guidance for stakeholder engagement in health and healthcare guideline development and implementation.

Petkovic J, Riddle A, Akl EA, Khabsa J, Lytvyn L, Atwere P, Campbell P, Chalkidou K, Chang SM, Crowe S, Dans L, Jardali FE, Ghersi D, Graham ID, Grant S, Greer-Smith R, Guise JM, Hazlewood G, Jull J, Katikireddi SV, Langlois EV, Lyddiatt A, Maxwell L, Morley R, Mustafa RA, Nonino F, Pardo JP, Pollock A, Pottie K, Riva J, Schünemann H, Simeon R, Smith M, Stein AT, Synnot A, Tufte J, White H, Welch V, Concannon TW, Tugwell P.

Syst Rev. 2020 Feb 1;9(1):21. doi: 10.1186/s13643-020-1272-5.

2.

Appraisal of the methodological quality of clinical practice guidelines in the Philippines.

Miguel RTD, Silvestre MAA, Imperial MLS, Ho BLC, Dans LF.

Int J Health Plann Manage. 2019 Oct;34(4):e1723-e1735. doi: 10.1002/hpm.2886. Epub 2019 Aug 21.

PMID:
31433544
3.

Dengue infection and advances in dengue vaccines for children.

Halstead SB, Dans LF.

Lancet Child Adolesc Health. 2019 Oct;3(10):734-741. doi: 10.1016/S2352-4642(19)30205-6. Epub 2019 Aug 1. Review.

PMID:
31378686
4.

Impact of improved primary care on patient satisfaction: Results of a pilot study in the University of the Philippines.

De Mesa RYH, Galingana CLT, Marfori JRA, Rey MP, Sundiang NB, Celeste JT, Dans LF, Dans AML, Catabui JT.

Int J Health Plann Manage. 2019 Oct;34(4):e1651-e1660. doi: 10.1002/hpm.2862. Epub 2019 Jul 29.

PMID:
31359486
5.

Reporting of data monitoring committees and adverse events in paediatric trials: a descriptive analysis.

Gates A, Caldwell P, Curtis S, Dans L, Fernandes RM, Hartling L, Kelly LE, Vandermeer B, Williams K, Woolfall K, Dyson MP.

BMJ Paediatr Open. 2019 Mar 20;3(1):e000426. doi: 10.1136/bmjpo-2018-000426. eCollection 2019.

6.

2018 APLAR axial spondyloarthritis treatment recommendations.

Tam LS, Wei JC, Aggarwal A, Baek HJ, Cheung PP, Chiowchanwisawakit P, Dans L, Gu J, Hagino N, Kishimoto M, Reyes HM, Soroosh S, Stebbings S, Whittle S, Yeap SS, Lau CS.

Int J Rheum Dis. 2019 Mar;22(3):340-356. doi: 10.1111/1756-185X.13510. Epub 2019 Feb 28.

PMID:
30816645
7.

2018 update of the APLAR recommendations for treatment of rheumatoid arthritis.

Lau CS, Chia F, Dans L, Harrison A, Hsieh TY, Jain R, Jung SM, Kishimoto M, Kumar A, Leong KP, Li Z, Lichauco JJ, Louthrenoo W, Luo SF, Mu R, Nash P, Ng CT, Suryana B, Wijaya LK, Yeap SS.

Int J Rheum Dis. 2019 Mar;22(3):357-375. doi: 10.1111/1756-185X.13513. Epub 2019 Feb 27.

PMID:
30809944
8.

Antiamoebic drugs for treating amoebic colitis.

Gonzales MLM, Dans LF, Sio-Aguilar J.

Cochrane Database Syst Rev. 2019 Jan 9;1:CD006085. doi: 10.1002/14651858.CD006085.pub3.

9.

Consent and recruitment: the reporting of paediatric trials published in 2012.

Gates A, Caldwell P, Curtis S, Dans L, Fernandes RM, Hartling L, Kelly LE, Williams K, Woolfall K, Dyson MP.

BMJ Paediatr Open. 2018 Nov 26;2(1):e000369. doi: 10.1136/bmjpo-2018-000369. eCollection 2018.

10.

Cause and consequence of loss in vaccine trust.

Dans AL, Dans LF, Silvestre MAA, Halstead SB, Guyatt GH.

Hum Vaccin Immunother. 2019;15(3):628-629. doi: 10.1080/21645515.2018.1551674. Epub 2018 Dec 11. No abstract available.

11.

Controversy and debate on dengue vaccine series-paper 3: final response to review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs.

Dans AL, Dans LF, Lansang MAD, Silvestre MAA, Guyatt GH.

J Clin Epidemiol. 2018 Mar;95:142. doi: 10.1016/j.jclinepi.2017.12.025. Epub 2018 Jan 3. No abstract available.

PMID:
29306065
12.

Controversy and debate on dengue vaccine series-paper 1: review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs.

Dans AL, Dans LF, Lansang MAD, Silvestre MAA, Guyatt GH.

J Clin Epidemiol. 2018 Mar;95:137-139. doi: 10.1016/j.jclinepi.2017.11.019. Epub 2017 Nov 24. Review.

PMID:
29180056
13.

GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidence.

Welch VA, Akl EA, Pottie K, Ansari MT, Briel M, Christensen R, Dans A, Dans L, Eslava-Schmalbach J, Guyatt G, Hultcrantz M, Jull J, Katikireddi SV, Lang E, Matovinovic E, Meerpohl JJ, Morton RL, Mosdol A, Murad MH, Petkovic J, Schünemann H, Sharaf R, Shea B, Singh JA, Solà I, Stanev R, Stein A, Thabaneii L, Tonia T, Tristan M, Vitols S, Watine J, Tugwell P.

J Clin Epidemiol. 2017 Oct;90:76-83. doi: 10.1016/j.jclinepi.2017.01.015. Epub 2017 Apr 4.

14.

Evidence for underuse of effective medical services around the world.

Glasziou P, Straus S, Brownlee S, Trevena L, Dans L, Guyatt G, Elshaug AG, Janett R, Saini V.

Lancet. 2017 Jul 8;390(10090):169-177. doi: 10.1016/S0140-6736(16)30946-1. Epub 2017 Jan 9. Review.

PMID:
28077232
15.

Polymer-based oral rehydration solution for treating acute watery diarrhoea.

Gregorio GV, Gonzales ML, Dans LF, Martinez EG.

Cochrane Database Syst Rev. 2016 Dec 13;12:CD006519. doi: 10.1002/14651858.CD006519.pub3. Review.

16.

Harnessing and supporting consumer involvement in the development and implementation of Models of Care for musculoskeletal health.

Walsh L, Hill S, Wluka AE, Brooks P, Buchbinder R, Cahill A, Dans LF, Lowe D, Taylor M, Tugwell P.

Best Pract Res Clin Rheumatol. 2016 Jun;30(3):420-444. doi: 10.1016/j.berh.2016.09.004. Review.

PMID:
27886940
17.

Revering the irreverent.

Dans AL, Dans LF.

J Clin Epidemiol. 2016 May;73:64-6. doi: 10.1016/j.jclinepi.2016.02.013. Epub 2016 Feb 28. No abstract available.

PMID:
26931295
18.

Isotonic versus hypotonic saline solution for maintenance intravenous fluid therapy in children: a systematic review.

Padua AP, Macaraya JR, Dans LF, Anacleto FE Jr.

Pediatr Nephrol. 2015 Jul;30(7):1163-72. doi: 10.1007/s00467-014-3033-y. Epub 2015 Jan 11. Review.

PMID:
25576065
19.

Moringa oleifera as a Galactagogue.

Raguindin PF, Dans LF, King JF.

Breastfeed Med. 2014 Jul-Aug;9(6):323-4. doi: 10.1089/bfm.2014.0002. Epub 2014 Jun 3. No abstract available.

PMID:
24892837
20.

Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock.

Alejandria MM, Lansang MA, Dans LF, Mantaring JB 3rd.

Cochrane Database Syst Rev. 2013 Sep 16;(9):CD001090. doi: 10.1002/14651858.CD001090.pub2. Review.

21.

IndiaCLEN.

Dans AM, Dans LF.

J Clin Epidemiol. 2013 Jan;66(1):3. doi: 10.1016/j.jclinepi.2012.10.009. No abstract available.

22.

Standard 1: consent and recruitment.

Caldwell PH, Dans L, de Vries MC, Newman Ba Hons J, Sammons H, Spriggs M Bioeth M, Tambe P, Van't Hoff W, Woolfall K, Young B, Offringa M; StaR Child Health Group.

Pediatrics. 2012 Jun;129 Suppl 3:S118-23. doi: 10.1542/peds.2012-0055D. Review. No abstract available.

PMID:
22661757
23.

Early versus Delayed Refeeding for Children with Acute Diarrhoea.

Gregorio GV, Dans LF, Silvestre MA.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD007296. doi: 10.1002/14651858.CD007296.pub2. Review.

24.

Clinical presentations and outcomes of Filipino juvenile systemic lupus erythematosus.

Gulay CB, Dans LF.

Pediatr Rheumatol Online J. 2011 Feb 9;9:7. doi: 10.1186/1546-0096-9-7.

25.

Trade-off between benefit and harm is crucial in health screening recommendations. Part I: general principles.

Dans LF, Silvestre MA, Dans AL.

J Clin Epidemiol. 2011 Mar;64(3):231-9. doi: 10.1016/j.jclinepi.2010.09.009. Epub 2010 Dec 30.

PMID:
21194890
26.

Trade-off between benefit and harm is crucial in health screening recommendations. Part II: evidence summaries.

Silvestre MA, Dans LF, Dans AL.

J Clin Epidemiol. 2011 Mar;64(3):240-9. doi: 10.1016/j.jclinepi.2010.09.008. Epub 2010 Dec 30.

PMID:
21194888
27.

Probiotics for treating acute infectious diarrhoea.

Allen SJ, Martinez EG, Gregorio GV, Dans LF.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD003048. doi: 10.1002/14651858.CD003048.pub3. Review.

28.

Development of a questionnaire for identification of the risk factors for osteoarthritis of the knees in developing countries. A pilot study in Iran and Bangladesh. An ILAR-COPCORD phase III study.

Haq SA, Davatchi F, Dahaghin S, Islam N, Ghose A, Darmawan J, Chopra A, Yu ZQ, Dans LF, Rasker JJ.

Int J Rheum Dis. 2010 Aug;13(3):203-14. doi: 10.1111/j.1756-185X.2010.01529.x.

PMID:
20704616
29.

Appraising a tool for guideline appraisal (the AGREE II instrument).

Dans AL, Dans LF.

J Clin Epidemiol. 2010 Dec;63(12):1281-2. doi: 10.1016/j.jclinepi.2010.06.005. Epub 2010 Jul 6. No abstract available.

PMID:
20605571
30.

Polymer-based oral rehydration solution for treating acute watery diarrhoea.

Gregorio GV, Gonzales ML, Dans LF, Martinez EG.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006519. doi: 10.1002/14651858.CD006519.pub2. Review. Update in: Cochrane Database Syst Rev. 2016 Dec 13;12 :CD006519.

PMID:
19370638
31.

Antiamoebic drugs for treating amoebic colitis.

Gonzales ML, Dans LF, Martinez EG.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006085. doi: 10.1002/14651858.CD006085.pub2. Review. Update in: Cochrane Database Syst Rev. 2019 Jan 09;1:CD006085.

PMID:
19370624
32.

Zinc supplementation reduced cost and duration of acute diarrhea in children.

Gregorio GV, Dans LF, Cordero CP, Panelo CA.

J Clin Epidemiol. 2007 Jun;60(6):560-6. Epub 2006 Dec 11.

PMID:
17493510
33.

Assessing equity in clinical practice guidelines.

Dans AM, Dans L, Oxman AD, Robinson V, Acuin J, Tugwell P, Dennis R, Kang D.

J Clin Epidemiol. 2007 Jun;60(6):540-6. Epub 2007 Jan 18. Review.

PMID:
17493507
34.

Amoebic dysentery.

Dans LF, Martínez EG.

BMJ Clin Evid. 2007 Jan 1;2007. pii: 0918. Review.

35.

Amoebic dysentery.

Dans L, Martínez E.

Clin Evid. 2006 Jun;(15):1007-13. Review. No abstract available.

PMID:
16973041
36.

Amoebic dysentery.

Dans L, Martínez E.

Clin Evid. 2005 Dec;(14):869-74. Review. No abstract available. Update in: Clin Evid. 2006 Jun;(15):1007-13.

PMID:
16620441
37.

Cost-benefit analysis of newborn screening for galactosemia in the Philippines.

Padilla CD, Dans LF, Estrada SC, Tamondong MR Jr, Laceste JJ, Bernal RM.

Southeast Asian J Trop Med Public Health. 2003;34 Suppl 3:215-20.

PMID:
15906739
38.

Amoebic dysentery.

Dans L, Martinez E.

Clin Evid. 2004 Dec;(12):1043-9. Review. No abstract available. Update in: Clin Evid. 2005 Dec;(14):869-74.

PMID:
15865700
39.

Probiotics for treating infectious diarrhoea.

Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF.

Cochrane Database Syst Rev. 2004;(2):CD003048. Review. Update in: Cochrane Database Syst Rev. 2010;(11):CD003048.

PMID:
15106189
40.

Intravenous immunoglobulin for treating sepsis and septic shock.

Alejandria MM, Lansang MA, Dans LF, Mantaring JB.

Cochrane Database Syst Rev. 2002;(1):CD001090. Review. Update in: Cochrane Database Syst Rev. 2013;9:CD001090.

PMID:
11869591
41.

Intravenous immunoglobulin for treating sepsis and septic shock.

Alejandria MM, Lansang MA, Dans LF, Mantaring JB.

Cochrane Database Syst Rev. 2001;(2):CD001090. Review. Update in: Cochrane Database Syst Rev. 2002;(1):CD001090.

PMID:
11405973
42.

The need and means for evidence-based medicine in developing countries.

Dans AL, Dans LF.

ACP J Club. 2000 Jul-Aug;133(1):A11-2. No abstract available.

PMID:
10906850
43.

Intravenous immunoglobulin for treating sepsis and septic shock.

Alejandria MM, Lansang MA, Dans LF, Mantaring JB.

Cochrane Database Syst Rev. 2000;(2):CD001090. Review. Update in: Cochrane Database Syst Rev. 2001;(2):CD001090.

PMID:
10796589
44.

Applying the results of trials and systematic reviews to individual patients.

Glasziou P, Guyatt GH, Dans AL, Dans LF, Straus S, Sackett DL.

ACP J Club. 1998 Nov-Dec;129(3):A15-6.

PMID:
9825009
45.

Supplemental Content

Support Center